11 results
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
/ Breakthrough DVT ... Structural - Pelvic masses ... Breakthrough #Recurrent #DVT ... #VTE #anticoagulation ... #hematology #differential
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Venous Thrombosis - Management ... Superficial #Deep #VTE ... #DVT #Hematology ... #Management #Anatomy ... #Anticoagulation
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
Venous Thrombosis - Management ... Superficial #Deep #VTE ... #DVT #Hematology ... #Management #Anatomy ... #Anticoagulation
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
@Clotmaster #Management ... #VTE #DVT #Algorithm ... Thromboembolism #Treatment #Hematology ... #Anticoagulation
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Algorithm #Anticoagulation ... Algorithm #Extension #VTE ... #DVT #Hematology ... #Differential # ... Causes
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
DVT = deep vein ... body mass index; VTE ... #DOAC #VTE #Malignancy ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
algorithm for VTE ... and incidental DVT ... without concomitant DVT ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
of about three cases ... Lymphoma (90-95% of cases ... Immunohistochemical studies (to differentiate ... classification #hematology ... #oncology #management
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Upper Extremity DVT ... DeLoughery @Bloodman #VTE ... #anticoagulation ... #duration #management ... #DVT #hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Isolated distal DVT ... Unprovoked proximal DVT ... therapy - Second VTE ... Treatment #Algorithm #management ... #hematology #anticoagulation